comparemela.com

Marke Pruzanski News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Positive Report for Intercept Pharma (ICPT) from H C Wainwright

Intercept Pharma (ICPT – Research Report) received a Buy rating and a $19.00 price target from H.C. Wainwright analyst Ed Arce today. The .

New yorkUnited statesEd arceMarke pruzanskiCanaccord genuity edward nashIntercept pharmaceuticals incIntercept pharmaResearch reportAkebia therapeuticsCanaccord genuityEdward nashRoberto pellicciari

B Riley Financial Remains a Buy on Intercept Pharma (ICPT)

In a report released today, Mayank Mamtani from B.Riley Financial reiterated a Buy rating on Intercept Pharma (ICPT – Research Report), wi.

New yorkUnited statesPiper sandlerMarke pruzanskiMayank mamtaniIntercept pharmaceuticals incIntercept pharmaResearch reportModerate buyRoberto pellicciari

RBC Capital Reaffirms Their Hold Rating on Intercept Pharma (ICPT)

RBC Capital analyst Brian Abrahams maintained a Hold rating on Intercept Pharma (ICPT – Research Report) on January 13 and set a price tar.

New yorkUnited statesMarke pruzanskiBrian abrahamsIntercept pharmaceuticals incResearch report onIntercept pharmaResearch reportModerate buyRoberto pellicciari

B Riley Financial Sticks to Its Hold Rating for Intercept Pharma (ICPT)

B Riley Financial Sticks to Its Hold Rating for Intercept Pharma (ICPT)
markets.co - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from markets.co Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesMarke pruzanskiMayank mamtaniArrowhead pharmaceuticalsIntercept pharmaceuticals incSpectrum pharmaceuticalsMadrigal pharmaceuticalsIntercept pharmaResearch reportRoberto pellicciari

vimarsana © 2020. All Rights Reserved.